Skip to main content

HTG Molecular Diagnostics, Inc. (HTGM)

NASDAQ: HTGM · IEX Real-Time Price · USD
5.71 0.06 (1.06%)
Oct 21, 2021 2:40 PM EDT - Market open
Market Cap41.81M
Revenue (ttm)7.87M
Net Income (ttm)-17.17M
Shares Out6.69M
EPS (ttm)-3.04
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,994
Open5.69
Previous Close5.65
Day's Range5.66 - 5.85
52-Week Range3.50 - 7.95
Beta1.48
AnalystsBuy
Price Target9.75 (+70.8%)
Est. Earnings DateNov 9, 2021

About HTGM

HTG Molecular Diagnostics, Inc. a commercial stage life sciences company, focuses on the precision medicine. The company offers instrumentation; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its platforms generate a molecular profiling library for detection using next-generation sequencing. The company's marketed panels include HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq D...

IndustryHealth Care Technology
IPO DateMay 6, 2015
CEOJohn Lubniewski
Employees83
Stock ExchangeNASDAQ
Ticker SymbolHTGM
Full Company Profile

Financial Performance

In 2020, HTGM's revenue was $8.55 million, a decrease of -55.48% compared to the previous year's $19.20 million. Losses were -$20.87 million, 8.15% more than in 2019.

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for HTGM stock is "Buy." The 12-month stock price forecast is 9.75, which is an increase of 70.75% from the latest price.

Price Target
$9.75
(70.75% upside)
Analyst Consensus: Buy

News

HTG Expands Therapeutics Team

Veteran Drug Developer Stephen Barat, Ph.D. Joins to Head Company's Therapeutics Division Veteran Drug Developer Stephen Barat, Ph.D. Joins to Head Company's Therapeutics Division

2 weeks ago - GlobeNewsWire

HTG Molecular Diagnostics to Present at H.C. Wainwright's 23rd Annual Global Investment Conference

TUCSON, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that compan...

1 month ago - GlobeNewsWire

HTG Molecular Diagnostics Reports Second Quarter 2021 Results

Call scheduled for today, August 12, at 4:30pm ET Call scheduled for today, August 12, at 4:30pm ET

2 months ago - GlobeNewsWire

HTG's New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe

HTG Transcriptome Panel designed to measure approximately 20,000 mRNA targets using the  HTG EdgeSeq technology

2 months ago - GlobeNewsWire

HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TUCSON, Ariz., July 23, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that, on Jul...

2 months ago - GlobeNewsWire

HTG Receives First Order For HTG Transcriptome Panel, Enters Two European EAP Agreements

HTG Molecular Diagnostics Inc (NASDAQ: HTGM) has received the first commercial orders for its planned HTG Transcriptome Panel and has signed agreements with its first two Early Adopter Program (EAP) col...

3 months ago - Benzinga

HTG EdgeSeq Technology Highlighted in Several Posters Being Presented at the American Society of Clinical Oncology 20...

TUCSON, Ariz., May 24, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that its HTG ...

4 months ago - GlobeNewsWire

HTG Molecular Diagnostics Reports First Quarter 2021 Results and Provides a Corporate Update

Call scheduled for today, May 13, at 4:30 pm ET Call scheduled for today, May 13, at 4:30 pm ET

5 months ago - GlobeNewsWire

HTG Molecular Diagnostics to Announce Q1 2021 Financial Results and Host Conference Call on Thursday, May 13

TUCSON, Ariz., May 04, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report...

5 months ago - GlobeNewsWire

HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results

TUCSON, Ariz., April 05, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today reported certain prel...

6 months ago - GlobeNewsWire

HTG Molecular Diagnostics Reports Full Year 2020 Results

Call scheduled for today, March 25, at 4:30pm ET Call scheduled for today, March 25, at 4:30pm ET

6 months ago - GlobeNewsWire

Earnings Preview: HTG Molecular Diagnostics, Inc. (HTGM) Q4 Earnings Expected to Decline

HTG Molecular Diagnostics, Inc. (HTGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25

TUCSON, Ariz., March 16, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will repo...

7 months ago - GlobeNewsWire

3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy

Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a $1.8 billion deal on Monday, the same day Veracyte Inc (NASDAQ: VCYT) announced it completed the acquisition of Deciph...

Other symbols:BIOC
7 months ago - Benzinga

HTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG E...

TUCSON, Ariz., Feb. 26, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has compl...

7 months ago - GlobeNewsWire

HTG Announces Board of Directors Transition

Timothy Johnson to Retire from the Board; Ann Hanham, Ph.D. Remains Lead Independent Director Timothy Johnson to Retire from the Board; Ann Hanham, Ph.D. Remains Lead Independent Director

9 months ago - GlobeNewsWire

HTG Expands Patent Portfolio with New Canadian Patent for its Nuclease Protection Methods for Detection of Nucleotide...

TUCSON, Ariz., Dec. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has ...

9 months ago - GlobeNewsWire

HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel

TUCSON, Ariz., Dec. 18, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has ...

10 months ago - GlobeNewsWire

HTG Announces an Early Access Program for its Prototype Whole Transcriptome Panel

TUCSON, Ariz., Dec. 08, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has ...

10 months ago - GlobeNewsWire

HTG Announces One-for-Fifteen Reverse Stock Split

TUCSON, Ariz., Nov. 23, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that as a result o...

10 months ago - GlobeNewsWire

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q3 2020 Results - Earnings Call Transcript

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q3 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

HTG Molecular Diagnostics: Q3 Earnings Insights

Shares of HTG Molecular Diagnostics (NASDAQ:HTGM) decreased 3.2% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 53.33% year over year to ($0.07)...

11 months ago - Benzinga

HTG Molecular Diagnostics Reports Third Quarter 2020 Results

Call scheduled for today, November 10, at 4:30pm ET Call scheduled for today, November 10, at 4:30pm ET

11 months ago - GlobeNewsWire

HTG Demonstrates Technical Feasibility for a Whole Transcriptome Panel Using HTG EdgeSeq Technology

TUCSON, Ariz., Nov. 02, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the completi...

11 months ago - GlobeNewsWire

HTG Molecular Diagnostics to Announce Third Quarter 2020 Financial Results and Host Conference Call on Tuesday, Novem...

TUCSON, Ariz., Oct. 30, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will repor...

11 months ago - GlobeNewsWire